RE: One of the best covid bits of news1 May 2020 04:36
“it is essential that we have the ability to rapidly stratify individuals into those that will progress to severe disease, and those that will respond to available therapies. Evaluation of the immunological set-point via EpiSwitchTM will provide that much needed stratification tool.’
Professor at uni Glasgow